Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046455004> ?p ?o ?g. }
- W2046455004 endingPage "3993" @default.
- W2046455004 startingPage "3987" @default.
- W2046455004 abstract "The impact of adding vinblastine to a 4-month chemotherapy regimen, based on the Non-Hodgkin's Lymphoma Berlin-Frankfurt-Münster 90 protocol, in childhood high-risk anaplastic large-cell lymphoma (ALCL) was assessed.Children and adolescents with high-risk ALCL, defined by mediastinal, lung, liver, spleen, or skin involvement, were eligible for the trial. After a prephase and one chemotherapy course, patients were randomly assigned to receive either five further chemotherapy courses without vinblastine or the same regimen with one vinblastine injection (6 mg/m(2)) during each course followed by weekly vinblastine to complete a total of 1 year of treatment. The primary end point was event-free survival (EFS), analyzed on the intent-to-treat population.Between November 1999 and June 2006, 110 patients were randomly assigned to receive vinblastine, and 107 were randomly assigned not to receive vinblastine. Median follow-up was 4.8 years. Patients in the vinblastine arm had a significantly reduced risk of events during the first year (hazard ratio [HR] = 0.31; 95% CI, 0.15 to 0.67; P = .002) followed by an increased risk thereafter (HR = 4.98; 95% CI, 1.65 to 15.0; P = .003). Consequently, EFS at 1 year differed significantly (91% in the vinblastine group v 74% in the no-vinblastine group), with no difference at 2 years (73% and 70%, respectively). Overall EFS curves did not differ significantly (HR = 0.91; 95% CI, 0.55 to 1.5; P = .71). Thirty-one percent of weekly doses of vinblastine were reduced as a result of hematologic toxicity, although vinblastine was discontinued for toxicity in only three patients.Adding vinblastine during induction and as maintenance for a total treatment duration of 1 year significantly delayed the occurrence of relapses but did not reduce the risk of failure." @default.
- W2046455004 created "2016-06-24" @default.
- W2046455004 creator A5002010740 @default.
- W2046455004 creator A5006104396 @default.
- W2046455004 creator A5007763268 @default.
- W2046455004 creator A5017625077 @default.
- W2046455004 creator A5018249256 @default.
- W2046455004 creator A5019098042 @default.
- W2046455004 creator A5026131694 @default.
- W2046455004 creator A5031323468 @default.
- W2046455004 creator A5071405091 @default.
- W2046455004 creator A5077586946 @default.
- W2046455004 creator A5081946180 @default.
- W2046455004 creator A5082332900 @default.
- W2046455004 creator A5082583670 @default.
- W2046455004 creator A5087860986 @default.
- W2046455004 creator A5088776883 @default.
- W2046455004 creator A5090805735 @default.
- W2046455004 date "2010-09-01" @default.
- W2046455004 modified "2023-10-16" @default.
- W2046455004 title "Vinblastine in Children and Adolescents With High-Risk Anaplastic Large-Cell Lymphoma: Results of the Randomized ALCL99-Vinblastine Trial" @default.
- W2046455004 cites W1912693401 @default.
- W2046455004 cites W1939376872 @default.
- W2046455004 cites W1949104778 @default.
- W2046455004 cites W1968989618 @default.
- W2046455004 cites W1970045615 @default.
- W2046455004 cites W1985103890 @default.
- W2046455004 cites W1987876150 @default.
- W2046455004 cites W1988276378 @default.
- W2046455004 cites W1998074965 @default.
- W2046455004 cites W2001620074 @default.
- W2046455004 cites W2003429746 @default.
- W2046455004 cites W2004727085 @default.
- W2046455004 cites W2008448100 @default.
- W2046455004 cites W2019108602 @default.
- W2046455004 cites W2028678546 @default.
- W2046455004 cites W2041652923 @default.
- W2046455004 cites W2054989266 @default.
- W2046455004 cites W2058270690 @default.
- W2046455004 cites W2073663272 @default.
- W2046455004 cites W2083983168 @default.
- W2046455004 cites W2096804810 @default.
- W2046455004 cites W2107202569 @default.
- W2046455004 cites W2109078648 @default.
- W2046455004 cites W2128710193 @default.
- W2046455004 cites W2156226322 @default.
- W2046455004 cites W2158706332 @default.
- W2046455004 cites W2172268423 @default.
- W2046455004 cites W2263595010 @default.
- W2046455004 doi "https://doi.org/10.1200/jco.2010.28.5999" @default.
- W2046455004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20679620" @default.
- W2046455004 hasPublicationYear "2010" @default.
- W2046455004 type Work @default.
- W2046455004 sameAs 2046455004 @default.
- W2046455004 citedByCount "162" @default.
- W2046455004 countsByYear W20464550042012 @default.
- W2046455004 countsByYear W20464550042013 @default.
- W2046455004 countsByYear W20464550042014 @default.
- W2046455004 countsByYear W20464550042015 @default.
- W2046455004 countsByYear W20464550042016 @default.
- W2046455004 countsByYear W20464550042017 @default.
- W2046455004 countsByYear W20464550042018 @default.
- W2046455004 countsByYear W20464550042019 @default.
- W2046455004 countsByYear W20464550042020 @default.
- W2046455004 countsByYear W20464550042021 @default.
- W2046455004 countsByYear W20464550042022 @default.
- W2046455004 countsByYear W20464550042023 @default.
- W2046455004 crossrefType "journal-article" @default.
- W2046455004 hasAuthorship W2046455004A5002010740 @default.
- W2046455004 hasAuthorship W2046455004A5006104396 @default.
- W2046455004 hasAuthorship W2046455004A5007763268 @default.
- W2046455004 hasAuthorship W2046455004A5017625077 @default.
- W2046455004 hasAuthorship W2046455004A5018249256 @default.
- W2046455004 hasAuthorship W2046455004A5019098042 @default.
- W2046455004 hasAuthorship W2046455004A5026131694 @default.
- W2046455004 hasAuthorship W2046455004A5031323468 @default.
- W2046455004 hasAuthorship W2046455004A5071405091 @default.
- W2046455004 hasAuthorship W2046455004A5077586946 @default.
- W2046455004 hasAuthorship W2046455004A5081946180 @default.
- W2046455004 hasAuthorship W2046455004A5082332900 @default.
- W2046455004 hasAuthorship W2046455004A5082583670 @default.
- W2046455004 hasAuthorship W2046455004A5087860986 @default.
- W2046455004 hasAuthorship W2046455004A5088776883 @default.
- W2046455004 hasAuthorship W2046455004A5090805735 @default.
- W2046455004 hasBestOaLocation W20464550041 @default.
- W2046455004 hasConcept C126322002 @default.
- W2046455004 hasConcept C141071460 @default.
- W2046455004 hasConcept C168563851 @default.
- W2046455004 hasConcept C207103383 @default.
- W2046455004 hasConcept C2776694085 @default.
- W2046455004 hasConcept C2777132456 @default.
- W2046455004 hasConcept C2779338263 @default.
- W2046455004 hasConcept C2781413609 @default.
- W2046455004 hasConcept C44249647 @default.
- W2046455004 hasConcept C71924100 @default.
- W2046455004 hasConcept C90924648 @default.
- W2046455004 hasConceptScore W2046455004C126322002 @default.
- W2046455004 hasConceptScore W2046455004C141071460 @default.